Reckitt Benckiser Group plc (RBGPF) Income Statement Analysis

See more : DraftKings Inc. (DKNG1.MX) Income Statement Analysis – Financial Results

Complete financial analysis of Reckitt Benckiser Group plc (RBGPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reckitt Benckiser Group plc, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.

You may be interested

Reckitt Benckiser Group plc (RBGPF)

Industry: Household & Personal Products

Sector: Consumer Defensive

Website: https://www.reckitt.com

About Reckitt Benckiser Group plc

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	14.61B	14.45B	13.23B	13.99B	12.85B	12.60B	11.51B	9.89B	8.87B	8.84B	10.04B	9.57B	9.49B	8.45B	7.75B	6.56B	5.27B	4.92B	4.18B	3.87B	3.71B	3.45B
Cost of Revenue	5.85B	6.09B	5.56B	5.56B	5.07B	4.96B	4.64B	3.87B	3.63B	3.74B	4.07B	4.03B	3.82B	3.33B	3.09B	2.67B	2.20B	2.13B	1.89B	1.75B	1.74B	1.68B
Gross Profit	8.76B	8.36B	7.68B	8.44B	7.78B	7.64B	6.87B	6.03B	5.25B	5.10B	5.97B	5.54B	5.66B	5.12B	4.66B	3.89B	3.07B	2.79B	2.29B	2.12B	1.98B	1.78B
Gross Profit Ratio	59.97%	57.85%	58.00%	60.28%	60.55%	60.61%	59.68%	60.92%	59.12%	57.67%	59.43%	57.88%	59.69%	60.58%	60.16%	59.27%	58.30%	56.66%	54.87%	54.79%	53.27%	51.42%
Research & Development	337.00M	325.00M	313.00M	288.00M	257.00M	223.00M	187.00M	149.00M	140.00M	146.00M	199.00M	171.00M	26.00M	33.00M	119.00M	102.00M	88.00M	82.00M	63.00M	66.00M	57.00M	54.00M
General & Administrative	1.38B	1.21B	1.19B	1.39B	740.00M	890.00M	728.00M	648.00M	575.00M	528.00M	692.00M	491.00M	578.00M	0.00	0.00	0.00	0.00	313.00M	0.00	0.00	0.00	0.00
Selling & Marketing	3.70B	3.44B	3.46B	3.61B	3.42B	3.17B	3.00B	2.46B	2.17B	2.25B	2.47B	2.32B	2.30B	0.00	2.10B	1.84B	1.50B	0.00	0.00	0.00	0.00	0.00
SG&A	5.09B	4.64B	4.65B	5.00B	4.16B	4.06B	3.72B	3.11B	2.74B	2.78B	3.16B	2.81B	2.88B	0.00	2.10B	1.84B	1.50B	313.00M	0.00	0.00	0.00	0.00
Other Expenses	807.00M	158.00M	-1.00M	-2.00M	202.00M	0.00	0.00	59.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	6.23B	5.13B	4.96B	5.29B	4.62B	4.59B	4.13B	3.62B	3.01B	2.93B	3.62B	3.10B	3.28B	3.02B	2.77B	2.38B	1.94B	1.72B	1.45B	1.36B	1.29B	1.19B
Cost & Expenses	12.08B	11.22B	10.52B	10.85B	9.68B	9.55B	8.78B	7.48B	6.63B	6.67B	7.70B	7.13B	7.10B	6.36B	5.86B	5.05B	4.13B	3.86B	3.34B	3.11B	3.03B	2.87B
Interest Income	6.00M	29.00M	29.00M	77.00M	161.00M	78.00M	60.00M	42.00M	21.00M	27.00M	25.00M	26.00M	23.00M	21.00M	17.00M	31.00M	22.00M	17.00M	32.00M	12.00M	24.00M	20.00M
Interest Expense	295.00M	257.00M	244.00M	363.00M	314.00M	403.00M	298.00M	58.00M	54.00M	65.00M	56.00M	41.00M	38.00M	12.00M	16.00M	62.00M	46.00M	53.00M	13.00M	27.00M	43.00M	52.00M
Depreciation & Amortization	470.00M	604.00M	429.00M	470.00M	436.00M	404.00M	268.00M	227.00M	171.00M	161.00M	171.00M	148.00M	157.00M	144.00M	139.00M	107.00M	93.00M	97.00M	91.00M	94.00M	84.00M	82.00M
EBITDA	3.17B	3.90B	465.00M	3.61B	3.78B	3.48B	2.98B	2.64B	2.42B	2.34B	2.05B	2.61B	2.56B	2.26B	2.05B	1.65B	1.35B	1.02B	980.00M	879.00M	792.00M	679.00M
EBITDA Ratio	21.67%	27.23%	29.99%	32.89%	29.89%	27.59%	26.23%	26.64%	27.42%	26.62%	25.30%	27.27%	27.05%	26.77%	26.40%	25.11%	23.76%	23.93%	23.00%	22.37%	21.55%	19.83%
Operating Income	2.53B	3.25B	3.49B	3.15B	-1.71B	3.05B	2.74B	2.41B	2.24B	2.16B	2.35B	2.44B	2.40B	2.13B	1.89B	1.51B	1.23B	910.00M	840.00M	749.00M	679.00M	576.00M
Operating Income Ratio	17.33%	22.48%	26.36%	22.48%	-13.34%	24.19%	23.78%	24.37%	25.25%	24.49%	23.35%	25.45%	25.25%	25.20%	24.39%	22.93%	23.40%	18.49%	20.10%	19.35%	18.29%	16.68%
Total Other Income/Expenses	-130.00M	-182.00M	544.00M	-1.27B	-153.00M	-338.00M	-238.00M	-16.00M	-33.00M	-38.00M	-31.00M	-150.00M	-19.00M	6.00M	1.00M	-31.00M	-24.00M	-36.00M	36.00M	9.00M	-19.00M	-31.00M
Income Before Tax	2.40B	3.07B	-260.00M	1.87B	-2.11B	2.72B	2.50B	2.39B	2.21B	2.13B	2.31B	2.42B	2.38B	2.14B	1.89B	1.47B	1.21B	874.00M	876.00M	758.00M	660.00M	545.00M
Income Before Tax Ratio	16.44%	21.22%	-1.96%	13.39%	-16.40%	21.61%	21.71%	24.20%	24.88%	24.06%	23.04%	25.30%	25.05%	25.27%	24.40%	22.46%	22.95%	17.76%	20.96%	19.58%	17.78%	15.78%
Income Tax Expense	753.00M	711.00M	-208.00M	720.00M	665.00M	536.00M	-894.00M	558.00M	463.00M	462.00M	574.00M	587.00M	622.00M	566.00M	474.00M	354.00M	271.00M	200.00M	207.00M	181.00M	171.00M	137.00M
Net Income	1.64B	2.33B	-52.00M	1.19B	-2.77B	2.16B	6.17B	1.83B	1.74B	3.22B	1.74B	1.82B	1.75B	1.57B	1.42B	1.12B	938.00M	674.00M	669.00M	577.00M	489.00M	408.00M
Net Income Ratio	11.25%	16.12%	-0.39%	8.48%	-21.58%	17.14%	53.61%	18.52%	19.64%	36.48%	17.32%	19.03%	18.40%	18.55%	18.29%	17.07%	17.80%	13.69%	16.01%	14.91%	13.17%	11.81%
EPS	2.27	3.27	-0.07	1.67	-3.91	3.06	8.79	2.60	2.44	4.47	2.42	2.51	2.40	2.17	1.99	1.58	1.31	0.94	0.92	0.81	0.69	0.58
EPS Diluted	2.29	3.26	-0.07	1.66	-3.91	3.05	8.68	2.57	2.41	4.41	2.38	2.48	2.37	2.14	1.95	1.55	1.28	0.92	0.90	0.77	0.66	0.56
Weighted Avg Shares Out	722.52M	715.28M	713.76M	710.91M	708.69M	705.90M	702.38M	704.16M	713.06M	720.82M	718.38M	724.24M	727.63M	724.19M	713.00M	710.57M	715.04M	720.69M	727.06M	714.86M	706.89M	704.35M
Weighted Avg Shares Out (Dil)	718.28M	717.49M	713.76M	713.75M	708.69M	709.00M	711.12M	714.30M	723.55M	730.74M	729.05M	733.00M	735.83M	733.30M	728.17M	724.11M	733.63M	734.20M	743.26M	754.55M	758.10M	756.53M

BANG and the board is done: Reckitt Benckiser completes clean sweep of C-suite

November 15, 2023proactiveinvestors.com

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) chairman Chris Sinclair will step down next year and be replaced by former Sky chief executive Jeremy Darroch, making a 12-month clean sweep at the top of the Vanish and Cilit Bang maker. Sinclair...

Reckitt Benckiser: Not A Bargain Despite Its Potential

November 6, 2023seekingalpha.com

Reckitt Benckiser has struggled to consistently exploit its portfolio of premium brands and return to its historical growth trajectory. The company's third-quarter performance was impacted by foreign exchange headwinds, but this does not necessarily indicate underlying weakness. The lack of...

Reckitt Benckiser: Still Optimistic For The Long Run

November 6, 2023seekingalpha.com

Reckitt Benckiser reported mediocre third quarter results and provided a strategy update recently. While that strategy update was mostly a reaffirmation that Reckitt Benckiser is positioned well in a growing market, it announced a new share buyback program. While the...

Top 40 High-Yield Blue-Chip U.K. Stocks: Autumn 2023

October 6, 2023seekingalpha.com

Dividend yield is actually a fairly reliable indicator of value and future returns. There is an elevated risk of dividend cuts and suspensions when yields are so high, but in many cases, that seems unlikely. The UK does offer rich...

Reckitt Benckiser names Nike exec as its new finance chief

August 23, 2023proactiveinvestors.co.uk

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has named Shannon Eisenhardt as its new chief financial officer, in another change in the top team at the consumer goods maker. The manufacturer of Nurofen and Dettol said Eisenhardt will join the business on October...

Reckitt Benckiser 'cheap', according to brokers

July 27, 2023proactiveinvestors.co.uk

Reckitt Benckiser is “cheap” compared to the sector and against its own history, according to Deutsch Bank, although it is “tough to re-rate.” However, the broker believes it is “only moderately cheap against the market.

Reckitt Benckiser Group plc (RBGPF) Q2 2023 Earnings Call Transcript

July 26, 2023seekingalpha.com

Reckitt Benckiser Group plc (OTCPK:RBGPF) Q2 2023 Earnings Call Transcript July 26, 2023 8:30 AM ET Company Participants Richard Joyce - IR Nicandro Durante - CEO Jeff Carr - CFO Kris Licht - CEO Designate Conference Call Participants Tom Sykes...

Reckitt Benckiser and Unilever tread cautiously on prices in face of inflation-weary consumers

July 26, 2023proactiveinvestors.co.uk

Both Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) today and Unilever PLC (LSE:ULVR) yesterday reported a slump in sales volumes as consumers seemingly reached the limit of how much they are willing to pay for big brands. These sector-mates, which both have appointed new...

Reckitt Benckiser reports revenue growth as confidence reiterated

July 26, 2023proactiveinvestors.co.uk

Durex and Veet owner Reckitt Benckiser said first-half revenues moved higher with the consumer goods reiterating its confidence amid a challenging backdrop. Revenue grew to £7.4bn in the first six months of the year, an 8.1% increase compared to the...

International Wide-Moat Stocks On Sale - The July 2023 Heat Map

July 7, 2023seekingalpha.com

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth it.

1 2 3 4 5 6

Source: https://incomestatements.info
Category: Stock Reports

Reckitt Benckiser Group plc (RBGPF) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories